Background Since little is known about the prevalence of patients with functional gastrointestinal disorders (FGID), this study was performed to clarify the prevalence of FGID, especially functional dyspepsia (FD), in new patients of an outpatient clinic with primary care physicians in Japan. Results Out of 5813 patients, 818 (14.1%) visited because of abdominal symptoms. Final diagnoses of the 818 patients were FGID (n = 320, 39.1%), organic gastrointestinal diseases (n = 237, 28.9%), organic non-GI disease (n = 135, 16.5%), and others (n = 126, 15.4%). The 320 patients with FGID had FD (n = 170), irritable bowel syndrome (IBS) (n = 68), and other FGIDs (n = 88). The rate of FGID or FD in all patients was 5.5% or 2.9%, respectively. Among outpatients (n = 381) who complained of upper abdominal symptoms, approximately 45% had FD. There was no gender difference in the frequency of FGID, FD, or IBS in all ages of patients. A lower incidence of FD was shown in female patients over 70 years old and a higher incidence of IBS in male patients under 29 years old. Discussion These results suggest that the prevalence of FGID, especially FD, is very high in an outpatient clinic with primary care physicians in Japan.
Introduction
Functional gastrointestinal disorders (FGID) are a variable combination of chronic or recurrent gastrointestinal symptoms not explained by structural or biochemical abnormalities [1] . FGIDs are one of the most important diseases for gastroenterologists because up to a half of their time may be spent caring for these patients [2, 3] . Among FGIDs, functional dyspepsia (FD) affects a numerically important group of patients with FGID who have chronic symptoms, such as upper abdominal pain and discomfort, that can be attributed to the gastroduodenal region [4] . Although FD is generally a non-life-threatening disorder that is not associated with a need for surgery or a reduction in survival, primary care physicians as well as gastroenterologists have to pay attention to FD patients because of their high prevalence and impaired quality of life [1, 5] .
Although the prevalence of FD in the general population in many countries has been reported, uninvestigated people who have dyspepsia symptoms do not necessarily visit a clinic. Although the majority of patients with unexplained dyspeptic syndrome continue to be symptomatic over the long-term despite periods of remission [6] , approximately 1 in 2 subjects is estimated to seek health care for their dyspeptic symptoms at some time in their life [7] . Pain severity and fear of serious diseases appear to be factors associated with consulting behavior [7, 8] .
Thus, FD in the general population consists of not only true FD patients, but also non-patient cases of FD. Since little is known about the prevalence of FD patients, this study was performed to clarify the prevalence of FGID, especially FD, in new patients of an outpatient clinic with primary care physicians in Japan to better understand the clinical features of FD.
Methods
We analyzed consecutive outpatients who first visited the Department of General Medicine, Asahikawa Medical College Hospital, between April 2004 and March 2009. Asahikawa Medical College Hospital is located in Asahikawa City, which has a population of approximately 350,000, in the middle of Hokkaido Island, the northernmost part of Japan. Approximately 250 doctors work in the 602-bed hospital to cover almost all of the medical problems. Among them, 5 or 6 primary care physicians work in the Department of General Medicine. New patients who come to the hospital by ambulance are always admitted to the emergency unit in this hospital. Therefore, such patients are not admitted to the Department of General Medicine. Out of new walk-in patients who visited outpatient departments in our hospital, the patients who have a letter for a specific department, such as the Department of Dermatology, go directly to that department. On the other hand, patients who have no letter from other doctors and do not know which department to visit come first to the Department of General Medicine. Approximately 10% of all new patients who visited our department had a letter of introduction from other doctors. Table 1 shows the major ICD-10 [9] diagnoses of all outpatients (n = 5813) evaluated in this study. All data were drawn from medical records and Computerized Physician Order Entry System in the hospital. Each parameter such as age, sex, and diagnosis was investigated from the source.
FGID was diagnosed when organic diseases had been excluded by a structural or biochemical abnormality in patients who complained of abdominal symptoms. FD was diagnosed when organic diseases had been excluded in patients who complained of upper abdominal symptoms. In the present study, upper abdominal symptoms included upper abdominal pain, abdominal discomfort in the area including the epigastrium, early satiety, fullness and nausea, but not heartburn. IBS was defined as a combination of frequent abdominal pain and altered bowel habits. The abdominal pain had to have 2 of the following 3 characteristics: (1) relieved by defecation, (2) associated with a change in stool frequency, or (3) associated with a change in stool form.
Diagnosis of acute gastritis/duodenitis, so-called acute gastroduodenal gastric lesions (AGDML), was made by endoscopy with findings of multiple gastric or duodenal erosions or hemorrhagic mucosal lesions according to previous reports [10, 11] .
Statistical analysis was made using v 2 test. A level of p \ 0.05 was considered to be statistically significant. Table 2 , demonstrating that we do not have to consider a time-dependent change of patient profiles in the present study. Out of 5813 patients, 818 (14.1%) visited our department because of abdominal symptoms. As shown in Fig. 1 and Table 3 , final diagnoses of 818 patients were FGID (n = 320, 39.1%), organic gastrointestinal diseases (n = 237, 28.9%), organic non-GI disease (n = 135, 16.5%), and others (n = 126, 15.4%). Table 2 reveals that the point prevalence of FGID was stable over 5 years (66/1120 = 5.9%, 82/1138 = 7.2%, 51/1137 = 4.5%, 61/1275 = 4.8%, and 60/1143 = 5.2%, respectively). Among organic GI diseases, the rate of acute enterocolitis was the highest (19.3%). The rate of each acute gastritis/duodenitis and gastroduodenal ulcers, diverticulitis of the large intestine, or gastro-esophageal reflux disease with esophagitis was more than 1% in patients who had complained of abdominal symptoms. Among non-GI organic diseases, the rate of diseases of the musculoskeletal system was highest (8.3%). The rate of disease of the urinary tract, mental and behavioral disorders, or female pelvic inflammatory diseases was more than 1% (Table 3) . We next focused on the prevalence of FD. FD was defined as being present in patients who had upper abdominal symptoms without organic diseases. Out of all 5813 patients, 381 (166 males and 214 females) (6.6%) visited our department because of their upper abdominal symptoms. Upper abdominal symptoms include upper abdominal pain, upper abdominal discomfort, fullness, early satiety, and nausea with or without vomiting. If organic diseases had been excluded, patients who chiefly complained of upper abdominal symptoms were diagnosed as having FD. The rate of final diagnoses in patients who complained of upper abdominal symptoms is shown in Table 4 . Of the patients, 170 (44.6%), 28 (7.3%), and 6 (1.6%) were diagnosed as having FD, IBS, and other FGID, respectively. Six patients had both FD and IBS. In other words, over 50% of patients who complained of upper abdominal symptoms were diagnosed with FGID including FD and IBS. Organic diseases such as gastric ulcers were identified in 126 patients (33.2%). Table 5 summarizes the data on the gender and age distribution of symptoms and FGID, FD, or IBS in the present study. Based on Table 5 , the incidence of FD in all patients was 2.9%. In addition, 320 patients with FGID as described above included FD (n = 170) and IBS (n = 68). As illustrated in Table 5 , with regard to the relationship between sex or age and the number of patients with FGID, FD, or IBS, there was no gender difference in the frequency of FGID in all ages of patients (male vs. female, 5.2 vs. 5.7%), FD (2.9 vs. 3.0%), or IBS (1.2 vs. 1.1%). It was also shown that the incidence of FD in female patients over 70 years old was statistically significantly lower (p = 0.005), and the odds ratio was 2.71 (95% CI, 1.31-5.63). In addition, the prevalence of IBS was higher among males under 29 years old. The higher incidence in male patients under 29 years old was statistically significant (p = 0.014), and the odds ratio was 2.41 (95% CI; 1.16-4.99). Table 6 demonstrates the number of patients who received endoscopy. Out of 170 patients who had been diagnosed with FD, 124 (73%) received gastroduodenoscopy to exclude organic upper GI diseases such as gastric ulcers. A third of patients with FD and IBS underwent colon fiberscopy in this study.
Discussion
Defining dyspepsia remains controversial, particularly concerning the overlap between heartburn and upper abdominal pain or discomfort [12] [13] [14] [15] . Also, dyspepsia is not a term usually understood by patients [16] , and it is not measurable as a self-reported item. In particular, the periodicity of symptoms and the rates of persistence of symptoms have been relatively inconsistent in the literature. For example, some investigations were performed during the lifetime of patients [17] [18] [19] and others for shortterm periods (a couple of months) [20, 21] . Thus, the term ''functional dyspepsia'' used in a number of reports that have been published does not necessarily mean the same clinical entity. The Rome Definition of FD was changed Patients with both FD and IBS (n = 6) were included (2) nausea (at least[3 times weekly), (3) vomiting (at least[3 times weekly), (4) early satiety, and (5) loss of appetite [22] . Thus, their definition was not equal to the Rome II or III criteria. Similarly, the definition of FD in this study was not equal to the definition of Rome II or Rome III criteria. In this study we have defined FD as having been diagnosed when organic diseases had been excluded in patients who complained of upper abdominal symptoms. In the present study, upper abdominal symptoms included upper abdominal pain, abdominal discomfort in the area including the epigastrium, early satiety, fullness, and nausea, but not heartburn. Based on our definition of FD as described above, the present study was performed.
In this study, we did not include the duration of symptoms, which is required for diagnosing FD by the Rome criteria; the definition of FD in this study was not equal to the Rome criteria as described above. We considered FD to be a disease in patients who complained of upper abdominal symptoms without any organic diseases that could explain the symptoms. In this case, the duration of symptoms should not necessarily be included. In fact, although a number of studies have examined the prevalence of FD so far, the duration of symptoms analyzed is distributed widely, as described above [17] [18] [19] [20] [21] . Therefore, we did not include the duration of symptoms in this study.
As described above, we did not use international criteria such as Rome III. FD as defined in this study should be described as the investigated patients with dyspepsia. Therefore, one may consider the possibility that the comparisons between this study and others in the literature regarding the prevalence of FD patients make no sense, suggesting that we have to pay attention to this point especially when the prevalence of FD is compared between this and other studies.
Although there is the above-mentioned limitation of interpretation, according to a systematic review by ElSerag et al. [23] , studies up to 2002 indicated that in the general population, the prevalence of uninvestigated dyspepsia was in the range of 10-40%. Two studies provided information sufficient to calculate the prevalence of FD and reported that it was 11.5-14.7%. One was a populationbased study in Norway [17, 18] . The lifetime prevalence of uninvestigated dyspepsia in the study was 12.1 per 100. The majority of participants with dyspepsia (88%) agreed to undergo endoscopy. The overall prevalence of FD was calculated to be 14.7%, which was equivalent to 54% of dyspepsia patients who underwent upper endoscopy. In the second study [24] that examined the prevalence of FD, only 20% of participants with dyspepsia had an upper endoscopy preformed. Of these, 93% were reported as having non-ulcer dyspepsia, giving a population-based prevalence of 11.5%. In the present study, the prevalence of FD was 2.9% in an outpatient clinic, being too small when compared with the prevalence of FD reported by previous investigators [23] . This may be because of the difference in the study design. The present results were obtained from a patient-based investigation, whereas previous findings were found by general population-based studies. In other words, we treated patients but not non-patients who visited our department and needed medical services. Uninvesigated dyspepsia patients do not necessarily need to visit clinics, as it has been reported that only one fourth of individuals with dyspepsia seek medical consultation [7, 25, 26] . It is therefore suggested that the finding of a lower prevalence of FD in this study than in the general population may be reasonable.
In addition to the prevalence of FD in the general population, a nationwide cross-sectional survey performed in 1997 of 900 randomly selected American Gastroenterological Association members demonstrated that FGIDs were the most common disorders (35%) [27] . In other words, approximately one third of all patients who visited gastroenterologists had FGID, including FD. In the present study, out of 5813 patients who visited an outpatient clinic with primary care physicians, 320 (5.5%) patients had FGID. If we mention only patients who complained of GI symptoms, 320 (39.1%) out of 818 patients had FGID, which is in good agreement with the rate of FGID among patients who should be treated by gastroenterologists. It is therefore suggested that the prevalence of FGID patients in Japan as evaluated by this present study would not be far from that in the USA.
It has been reported that a large majority of uninvestigated people with dyspepsia in the general population do not have organic diseases [28] [29] [30] . In the present study, out of 381 patients with upper abdominal symptoms, 126 (33.2%) had organic diseases that could explain their symptoms. In other words, we could not detect any organic diseases in two thirds of patients who complained of upper abdominal symptoms, supporting the above evidence.
According to a prospective cohort study using data from surveys of random samples from Olmsted County, MN, USA, in residents over a mean 12-year period, the prevalence of FGID was stable over time [29] . The present study in Japan demonstrated that over 5 years the point prevalence was stable for FGID (5.9, 7.2, 4.5, 4.8, or 5.2%, respectively), which is in agreement with the findings obtained from a prospective cohort study in the USA, although the study design was quite different in the two reports.
Usage of NSAIDs could possibly contribute to the symptoms [31] . Hollenz et al. have demonstrated that primary care patients with an average risk profile frequently develop dyspeptic symptoms requiring treatment [32] . According to our investigation of medical records, when chronic usage of NSAIDs was recognized, gastroduodenoscopy was usually performed. However, the present study failed to determne precisely in all cases whether the patients took NSAIDs or not. Of the FD patients diagnosed in this study, 73% received upper GI endoscopy, which revealed no gastroduodenal damage; this could explain the abdominal symptoms. Although all patients did not receive endoscopy, a majority of patients who had been diagnosed with FD in the present study indeed received an examination by endoscopy, suggesting that NSAIDs-induced gastroduodenal mucosal lesions were rarely present in the group of patients who had been diagnosed with FD. However, further studies are needed to clarify whether NSAIDs usage contributes to the abdominal symptoms even when gastrointestinal mucosal lesions are excluded by endoscopy.
One may speculate that symptoms overlap among FDs, gastroesophageal reflux disease, and IBS and that it is quite difficult to distinguish these diseases by the chief complaint. In fact, 6 out of 381 patients who complained of upper abdominal symptoms had both FD and IBS. Thus, we believe the data obtained in this study were carefully analyzed from a point of view that there might be an overlap of FD and IBS. Symptoms of FD, gastroesophageal reflux disease, and IBS overlap [33] . In this study, heartburn was not included as a symptom of upper abdominal symptoms. Therefore, we could exclude the possibility that gastroesophageal reflux disease was not diagnosed in patients who complained of upper abdominal symptoms. However, it is quite difficult to distinguish these diseases (FD, gastroesophageal reflux disease, and IBS) only by symptoms when the patients first visit the clinic. In the present study, we focused on outpatients who needed to visit to clarify their medical problems. Therefore, we sometimes could not pick up on symptoms other than the chief complaints. For example, we might fail to get the information that the patient had experienced heartburn recently when the chief complaint was lower abdominal pain. Thus, in such cases the physician may fail to detect that the paitent's diagnosis actually should be both IBS and gastroesophageal reflux disease. Such missing information could not be included in the study by the questionnaire for non-patients, i.e., the general population. Again, our clinical study possibly has reduced accuracy because of overlapping. Thus, these clinical limitations should be improved in the future.
Epidemiologic data of IBS from western countries show that IBS is dominant in females [34, 35] . However, there was no gender difference in the rate of IBS in this study. According to a recent report from Japan, the prevalence of IBS in females tended to be more than in males, but not significantly so (p \ 0.1). In addition, an epidemiological survey in Japan demonstrated that males had a higher prevalence of IBS [36] . These results suggest that there might not be a significant gender difference, especially in Japan, which could support the present finding that there was no gender difference in the prevalence of IBS in an outpatient clinic. It has also been demonstrated that the prevalence of IBS was relatively high among the 10-to 29-year-old males, which is in agreement with a recent publication on Japanese subjects [37] .
In contrast, a couple of reports have demonstrated that there is no gender difference in the prevalence of FD [38] . The present study also provided data showing that there was no gender difference in the prevalence of FD. With regard to the relationship between age and the prevalence of FD, a couple of studies on the general population have suggested that the prevalence of dyspepsia decreases with age [39] [40] [41] . The present study demonstrated that there was no age-dependent difference of prevalence of FD in males. On the other hand, a lower prevalence of FD was observed in females over 70 years old. In females over 70 years old, the prevalence of FD was much lower than that in the younger age group, suggesting that there might be an agedependent change that is associated with the pathophysiology of FD especially in females. Further studies are needed to elucidate the reason.
The present study demonstrated that among outpatients who complained of abdominal symptoms, approximately 40% had FGID. In addition, among outpatients who complained of upper GI symptoms, approximately 45% had FD. Thus, the present study clearly revealed that the prevalence of FGID, especially FD, was very high in an outpatient clinic with primary care physicians in Japan. The epidemiological findings about FGID in outpatients in Japan obtained in this study may help our daily clinical practice.
